Trial Profile
Evaluation of vardenafil for the treatment of subjective tinnitus: A controlled pilot study.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Dec 2014
Price :
$35
*
At a glance
- Drugs Vardenafil (Primary)
- Indications Tinnitus
- Focus Therapeutic Use
- Sponsors Bayer
- 08 Dec 2014 According to ClinicalTrial.gov record, planned number of patients changed from 40 to 43.
- 14 May 2008 New trial record.